Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;9(2):103-7.
doi: 10.14797/mdcj-9-2-103.

Endovascular techniques in limb salvage: infrapopliteal angioplasty

Affiliations
Review

Endovascular techniques in limb salvage: infrapopliteal angioplasty

Joseph J Naoum et al. Methodist Debakey Cardiovasc J. 2013 Apr.

Abstract

Critical limb ischemia (CLI) results from inadequate blood flow to supply and sustain the metabolic needs of resting muscle and tissue. Infragenicular atherosclerosis is the most common cause of CLI, and it is more likely to develop when multilevel or diffuse arterial disease coincides with compromised run-off to the foot. Reports of good technical and clinical outcomes have advanced the endovascular treatment options, which have gained a growing acceptance as the primary therapeutic strategy for CLI, especially in patients with significant risk factors for open surgical bypass. In fact, endovascular recanalization of below-the-knee arteries has proven to be feasible and safe, reduce the need for amputation, and improve wound healing. The distribution of various vascular territories or angiosomes in the foot has been recognized, and it appears advantageous to revascularize the artery supplying the territory directly associated with tissue loss. In addition, the targeted application and local delivery of drugs using drug-coated balloons (DCB) during angioplasty has the potential to improve patency rates compared to balloon angioplasty alone.

Keywords: angiosome; balloon angioplasty; chronic limb ischemia; critical limb ischemia; diabetes; drug coated balloon; infrapopliteal artery disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: All authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported.

Figures

Figure 1.
Figure 1.

References

    1. Hallett JW, Jr, Byrne J, Gayari MM, Ilstrup DM, Jacobsen SJ, Gray DT. Impact of arterial surgery and balloon angioplasty on amputation: a population based study of 1155 procedures between 1972 and 1992. J Vasc Surg. 1997 Jan;25(1):29–38. - PubMed
    1. Nehler MR, Coll JR, Hiatt WR, Regensteiner JG, Schnickel GT, Klenke WA, et al. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg. 2003 Jul;38(1):7–14. - PubMed
    1. Harris RW, Andros G, Dulawa LB, Oblath RW, Apyan R, Salles-Cunha S. The transition to “in situ” vein bypass grafts. Surg Gynecol Obstet. 1986 Jul;163(1):21–8. - PubMed
    1. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002 Dec;25(12):2238–43. - PubMed
    1. Walker SR, Yusuf SW, Hopkinson BR. A 10-year follow-up of patients presenting with ischemic rest pain of the lower limbs. Eur J Vasc Endovasc Surg. 1998 Jun;15(6):478–82. - PubMed